YAP1 and glioblastoma: Lastly, transient silencing of YAP1 (this study) or YAP‐inducible genes [26], as well as reduced GBM cell migration upon transient silencing of YAP, further confirms the validity of the Hippo pathway as a promising target for drug discovery.